1-10 of 10
David A. Scheinberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab

Todd L. Rosenblat, Michael R. McDevitt, Jorge A. Carrasquillo, Neeta Pandit-Taskar, Mark G. Frattini, Peter G. Maslak, Jae H. Park, Dan Douer, Dragan Cicic, Steven M. Larson, David A. Scheinberg, Joseph G. Jurcic
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 2030–2037.
https://doi.org/10.1158/1078-0432.CCR-21-3712
Published: 13 May 2022
View article titled, Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
Open the PDF for Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab in another window
Journal Articles

A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma

Marjorie G. Zauderer, Anne S. Tsao, Tao Dao, Katherine Panageas, W. Victoria Lai, Andreas Rimner, Valerie W. Rusch, Prasad S. Adusumilli, Michelle S. Ginsberg, Daniel Gomez, David Rice, Reza Mehran, David A. Scheinberg, Lee M. Krug
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7483–7489.
https://doi.org/10.1158/1078-0432.CCR-17-2169
Published: 14 December 2017
View article titled, A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Open the PDF for A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein

Nicholas Veomett, Tao Dao, Hong Liu, Jingyi Xiang, Dmitry Pankov, Leonid Dubrovsky, Joseph A. Whitten, Sun-Mi Park, Tatyana Korontsvit, Victoria Zakhaleva, Emily Casey, Michael Curcio, Michael G. Kharas, Richard J. O'Reilly, Cheng Liu, David A. Scheinberg
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (15): 4036–4046.
https://doi.org/10.1158/1078-0432.CCR-13-2756
Published: 31 July 2014
View article titled, Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
Open the PDF for Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein in another window
Includes: Supplementary data
Journal Articles

Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia

Todd L. Rosenblat, Michael R. McDevitt, Deborah A. Mulford, Neeta Pandit-Taskar, Chaitanya R. Divgi, Katherine S. Panageas, Mark L. Heaney, Suzanne Chanel, Alfred Morgenstern, George Sgouros, Steven M. Larson, David A. Scheinberg, Joseph G. Jurcic
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5303–5311.
https://doi.org/10.1158/1078-0432.CCR-10-0382
Published: 31 October 2010
View article titled, Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia
Open the PDF for Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia in another window
Journal Articles

Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells

Rena J. May, Tao Dao, Javier Pinilla-Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, Peter Maslak, David A. Scheinberg
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4547–4555.
https://doi.org/10.1158/1078-0432.CCR-07-0708
Published: 01 August 2007
View article titled, Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4<sup>+</sup> and CD8<sup>+</sup> T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells
Open the PDF for Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4<sup>+</sup> and CD8<sup>+</sup> T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells in another window
Journal Articles

Natural Killer Cells License Dendritic Cell Cross-Presentation of B Lymphoma Cell–Associated Antigens

Tao Dao, Marta Gomez-Nunez, Christophe Antczak, Barry Kappel, Jaspreet Singh Jaggi, Tatyana Korontsvit, Victoriya Zakhaleva, David A. Scheinberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8763–8772.
https://doi.org/10.1158/1078-0432.CCR-05-0975
Published: 16 December 2005
View article titled, Natural Killer Cells License Dendritic Cell Cross-Presentation of B Lymphoma Cell–Associated Antigens
Open the PDF for Natural Killer Cells License Dendritic Cell Cross-Presentation of B Lymphoma Cell–Associated Antigens in another window
Journal Articles

CD8+ T-Cell–Dependent Immunity Following Xenogeneic DNA Immunization against CD20 in a Tumor Challenge Model of B-Cell Lymphoma

Maria Lia Palomba, Wendy K. Roberts, Tao Dao, Gregory Manukian, Jose A. Guevara-Patiño, Jedd D. Wolchok, David A. Scheinberg, Alan N. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 370–379.
https://doi.org/10.1158/1078-0432.370.11.1
Published: 21 January 2005
View article titled, CD8<sup>+</sup> T-Cell–Dependent Immunity Following Xenogeneic DNA Immunization against CD20 in a Tumor Challenge Model of B-Cell Lymphoma
Open the PDF for CD8<sup>+</sup> T-Cell–Dependent Immunity Following Xenogeneic DNA Immunization against CD20 in a Tumor Challenge Model of B-Cell Lymphoma in another window
Journal Articles

Treatment of Neuroblastoma Meningeal Carcinomatosis with Intrathecal Application of α-Emitting Atomic Nanogenerators Targeting Disialo-Ganglioside GD2

Matthias Miederer, Michael R. McDevitt, Paul Borchardt, Ira Bergman, Kim Kramer, Nai-Kong V. Cheung, David A. Scheinberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6985–6992.
https://doi.org/10.1158/1078-0432.CCR-04-0859
Published: 22 October 2004
View article titled, Treatment of Neuroblastoma Meningeal Carcinomatosis with Intrathecal Application of α-Emitting Atomic Nanogenerators Targeting Disialo-Ganglioside GD2
Open the PDF for Treatment of Neuroblastoma Meningeal Carcinomatosis with Intrathecal Application of α-Emitting Atomic Nanogenerators Targeting Disialo-Ganglioside GD2 in another window
Journal Articles

Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids: Efficacy versus HER2/ neu Expression

Åse M. Ballangrud, Wei-Hong Yang, Stig Palm, Richard Enmon, Paul E. Borchardt, Virginia A. Pellegrini, Michael R. McDevitt, David A. Scheinberg, George Sgouros
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4489–4497.
https://doi.org/10.1158/1078-0432.CCR-03-0800
Published: 06 July 2004
View article titled, Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids: <subtitle>Efficacy <em>versus</em> HER2/ <em>neu</em> Expression</subtitle>
Open the PDF for Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids: <subtitle>Efficacy <em>versus</em> HER2/ <em>neu</em> Expression</subtitle> in another window
Journal Articles

Molecular Remission Induction with Retinoic Acid and Anti-CD33 Monoclonal Antibody HuM195 in Acute Promyelocytic Leukemia

Joseph G. Jurcic, Tony DeBlasio, Larry Dumont, Tzy-Jyun Yao, David A. Scheinberg
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 372–380.
Published: 01 February 2000
View article titled, Molecular Remission Induction with Retinoic Acid and Anti-CD33 Monoclonal Antibody HuM195 in Acute Promyelocytic Leukemia
Open the PDF for Molecular Remission Induction with Retinoic Acid and Anti-CD33 Monoclonal Antibody HuM195 in Acute Promyelocytic Leukemia in another window